In early T-cell precursor ALL (ETP-ALL), the aberrant expression of the transcription factor ZEB2 resulted in increased expression of IL7R, and ZEB2-induced IL7R upregulation promoted T-ALL cell survival in vitro and in vivo [59]. Here, IL7R is linked to acute lymphoblastic leukemia.